| Mrs Debra H Simmons, RNC | |
|
1401 Oak St, Grenada, MS 38901-4633 | |
| (662) 226-4010 | |
| (662) 226-4495 |
| Full Name | Mrs Debra H Simmons |
|---|---|
| Gender | Female |
| Speciality | Clinical Nurse Specialist - Women's Health |
| Location | 1401 Oak St, Grenada, Mississippi |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285620633 | NPI | - | NPPES |
| 00116294 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SW0102X | Clinical Nurse Specialist - Women's Health | R728179 (Mississippi) | Primary |
| Entity Name | Ms State Department Of Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053489260 PECOS PAC ID: 0244129245 Enrollment ID: O20040315000937 |
News Archive
Doctors at Long Island Jewish (LIJ) Medical Center recently discovered a link between a common chemotherapy drug and a serious bone disease called osteonecrosis of the jaw (ONJ).
People with cataract-related vision loss who have had cataract surgery to improve their sight are living longer than those with visual impairment who chose not to have the procedure, according to an Australian cohort study published this month in Ophthalmology, the journal of the American Academy of Ophthalmology. After comparing the two groups, the researchers found a 40 percent lower long-term mortality risk in those who had the surgery.
Medical progress of her 14-year follow up will be released in a letter published in the Aug. 19, 2004 issue of the New England Journal of Medicine.
A cardiac hormone signaling receptor abundantly expressed both in inflamed tissues and cancers appears to recruit stem cells that form the blood vessels needed to feed tumor growth, reports a new study by scientists at the University of South Florida Nanomedicine Research Center.
CEL-SCI Corporation announced today it has received approval from the North Mississippi Health Services Institutional Review Board ("IRB") to begin enrollment of subjects for a Phase III clinical trial of Multikine®, the Company's flagship immunotherapy developed as a first-line standard of care in treating head and neck cancer. An IRB is a group formally designated by an institution to review and monitor research involving human subjects and to ensure protection of their rights and welfare.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Debra H Simmons, RNC 1401 Oak St, Grenada, MS 38901-4633 Ph: (662) 226-4010 | Mrs Debra H Simmons, RNC 1401 Oak St, Grenada, MS 38901-4633 Ph: (662) 226-4010 |
News Archive
Doctors at Long Island Jewish (LIJ) Medical Center recently discovered a link between a common chemotherapy drug and a serious bone disease called osteonecrosis of the jaw (ONJ).
People with cataract-related vision loss who have had cataract surgery to improve their sight are living longer than those with visual impairment who chose not to have the procedure, according to an Australian cohort study published this month in Ophthalmology, the journal of the American Academy of Ophthalmology. After comparing the two groups, the researchers found a 40 percent lower long-term mortality risk in those who had the surgery.
Medical progress of her 14-year follow up will be released in a letter published in the Aug. 19, 2004 issue of the New England Journal of Medicine.
A cardiac hormone signaling receptor abundantly expressed both in inflamed tissues and cancers appears to recruit stem cells that form the blood vessels needed to feed tumor growth, reports a new study by scientists at the University of South Florida Nanomedicine Research Center.
CEL-SCI Corporation announced today it has received approval from the North Mississippi Health Services Institutional Review Board ("IRB") to begin enrollment of subjects for a Phase III clinical trial of Multikine®, the Company's flagship immunotherapy developed as a first-line standard of care in treating head and neck cancer. An IRB is a group formally designated by an institution to review and monitor research involving human subjects and to ensure protection of their rights and welfare.
› Verified 3 days ago